Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Molecular patterns of diffuse and nodular parathyroid hyperplasia in long-term hemodialysis

I. Týcová, SD. Sulková, J. Štěpánková, Z. Krejčík, MD. Merkerová, V. Stránecký, P. Hrubá, E. Girmanová, M. Černoch, K. Lipár, T. Marada, C. Povýšil, O. Viklický,

. 2016 ; 311 (4) : E720-E729. [pub] 20160906

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17023721

Secondary hyperparathyroidism is a well-known complication of end-stage renal disease (ESRD). Both nodular and diffuse parathyroid hyperplasia occur in ESRD patients. However, their distinct molecular mechanisms remain poorly understood. Parathyroid tissue obtained from ESRD patients who had undergone parathyroidectomy was used for Illumina transcriptome screening and subsequently for discriminatory gene analysis, pathway mapping, and gene annotation enrichment analysis. Results were further validated using quantitative RT-PCR on the independent larger cohort. Microarray screening proved homogeneity of gene transcripts in hemodialysis patients compared with the transplant cohort and primary hyperparathyroidism; therefore, further experiments were performed in hemodialysis patients only. Enrichment analysis conducted on 485 differentially expressed genes between nodular and diffuse parathyroid hyperplasia revealed highly significant differences in Gene Ontology terms and the Kyoto Encyclopedia of Genes and Genomes database in ribosome structure (P = 3.70 × 10(-18)). Next, quantitative RT-PCR validation of the top differently expressed genes from microarray analysis proved higher expression of RAN guanine nucleotide release factor (RANGRF; P < 0.001), calcyclin-binding protein (CACYBP; P < 0.05), and exocyst complex component 8 (EXOC8; P < 0.05) and lower expression of peptidylprolyl cis/trans-isomerase and NIMA-interacting 1 (PIN1; P < 0.01) mRNA in nodular hyperplasia. Multivariate analysis revealed higher RANGRF and lower PIN1 expression along with parathyroid weight to be associated with nodular hyperplasia. In conclusion, our study suggests the RANGRF transcript, which controls RNA metabolism, to be likely involved in pathways associated with the switch to nodular parathyroid growth. This transcript, along with PIN1 transcript, which influences parathyroid hormone secretion, may represent new therapeutical targets to cure secondary hyperparathyroidism.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023721
003      
CZ-PrNML
005      
20170828125615.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1152/ajpendo.00517.2015 $2 doi
035    __
$a (PubMed)27600827
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Týcová, Irena $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
245    10
$a Molecular patterns of diffuse and nodular parathyroid hyperplasia in long-term hemodialysis / $c I. Týcová, SD. Sulková, J. Štěpánková, Z. Krejčík, MD. Merkerová, V. Stránecký, P. Hrubá, E. Girmanová, M. Černoch, K. Lipár, T. Marada, C. Povýšil, O. Viklický,
520    9_
$a Secondary hyperparathyroidism is a well-known complication of end-stage renal disease (ESRD). Both nodular and diffuse parathyroid hyperplasia occur in ESRD patients. However, their distinct molecular mechanisms remain poorly understood. Parathyroid tissue obtained from ESRD patients who had undergone parathyroidectomy was used for Illumina transcriptome screening and subsequently for discriminatory gene analysis, pathway mapping, and gene annotation enrichment analysis. Results were further validated using quantitative RT-PCR on the independent larger cohort. Microarray screening proved homogeneity of gene transcripts in hemodialysis patients compared with the transplant cohort and primary hyperparathyroidism; therefore, further experiments were performed in hemodialysis patients only. Enrichment analysis conducted on 485 differentially expressed genes between nodular and diffuse parathyroid hyperplasia revealed highly significant differences in Gene Ontology terms and the Kyoto Encyclopedia of Genes and Genomes database in ribosome structure (P = 3.70 × 10(-18)). Next, quantitative RT-PCR validation of the top differently expressed genes from microarray analysis proved higher expression of RAN guanine nucleotide release factor (RANGRF; P < 0.001), calcyclin-binding protein (CACYBP; P < 0.05), and exocyst complex component 8 (EXOC8; P < 0.05) and lower expression of peptidylprolyl cis/trans-isomerase and NIMA-interacting 1 (PIN1; P < 0.01) mRNA in nodular hyperplasia. Multivariate analysis revealed higher RANGRF and lower PIN1 expression along with parathyroid weight to be associated with nodular hyperplasia. In conclusion, our study suggests the RANGRF transcript, which controls RNA metabolism, to be likely involved in pathways associated with the switch to nodular parathyroid growth. This transcript, along with PIN1 transcript, which influences parathyroid hormone secretion, may represent new therapeutical targets to cure secondary hyperparathyroidism.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fokální nodulární hyperplazie $x etiologie $x genetika $x terapie $7 D020518
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a regulace genové exprese $x genetika $7 D005786
650    _2
$a lidé $7 D006801
650    _2
$a primární hyperparatyreóza $x patologie $7 D049950
650    _2
$a sekundární hyperparatyreóza $x etiologie $x genetika $x terapie $7 D006962
650    _2
$a chronické selhání ledvin $x komplikace $x terapie $7 D007676
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multigenová rodina $x genetika $7 D005810
650    _2
$a paratyreoidea $x patologie $7 D010280
650    _2
$a parathormon $x krev $7 D010281
650    _2
$a paratyreoidektomie $7 D016105
650    _2
$a messenger RNA $x biosyntéza $x genetika $7 D012333
650    12
$a dialýza ledvin $7 D006435
650    _2
$a transkriptom $x genetika $7 D059467
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sulková, Sylvie Dusilová $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Hemodialysis Centre, University Hospital, Hradec Králové, Czech Republic.
700    1_
$a Štěpánková, Jitka $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Krejčík, Zdeněk $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
700    1_
$a Merkerová, Michaela Dostálová $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
700    1_
$a Stránecký, Viktor $u Institute of Inherited Metabolic Disorders, Charles University and 1st School of Medicine and General University Hospital, Prague, Czech Republic.
700    1_
$a Hrubá, Petra $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Girmanová, Eva $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Černoch, Marek $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Lipár, Květoslav $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Marada, Tomáš $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Povýšil, Ctibor $u Department of Pathology, Charles University and 1st School of Medicine and General University Hospital, Prague, Czech Republic; and.
700    1_
$a Viklický, Ondřej $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; ondrej.viklicky@ikem.cz.
773    0_
$w MED00000286 $t American journal of physiology. Endocrinology and metabolism $x 1522-1555 $g Roč. 311, č. 4 (2016), s. E720-E729
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27600827 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170828130201 $b ABA008
999    __
$a ok $b bmc $g 1239402 $s 984634
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 311 $c 4 $d E720-E729 $e 20160906 $i 1522-1555 $m American journal of physiology: endocrinology and metabolism $n Am J Physiol Endocrinol Metab $x MED00000286
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Archiving options